HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$0.40
Day range
$0.37 - $0.43
Year range
$0.13 - $3.34
Market cap
25.86M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.80M | -2.26% |
Net income | -5.58M | -11.16% |
Net profit margin | — | — |
Earnings per share | -0.10 | 23.08% |
EBITDA | -4.74M | 2.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.30M | -56.42% |
Total assets | 4.21M | -50.21% |
Total liabilities | 9.07M | -20.93% |
Total equity | -4.86M | — |
Shares outstanding | 68.34M | — |
Price to book | -4.98 | — |
Return on assets | -242.87% | — |
Return on capital | 733.66% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.58M | -11.16% |
Cash from operations | -3.28M | 29.32% |
Cash from investing | 196.00K | -81.12% |
Cash from financing | 3.35M | 1,308.40% |
Net change in cash | 263.00K | 107.80% |
Free cash flow | -1.62M | 42.56% |
About
Founded
2000
Website
Employees
29